Improving Clinical Practice Guidelines for Antenatal Corticosteroids: Incorporating a Decision Support Tool to Tackle the Uncertain Balance of Harms and Benefits
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 460
- Locations
- 4
- Primary Endpoint
- The change in frequency of clinical counselling about late preterm antenatal corticosteroids.
Study Overview
Brief Summary
The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age 18 year or older.
- •Delivered a live neonate at 34+0 to 36+6 weeks of gestation.
- •Speaks English.
- •Agrees to participate in the questionnaire during their first week post-partum.
- •Delivered at one of the six participating obstetrical hospitals.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
The change in frequency of clinical counselling about late preterm antenatal corticosteroids.
Time Frame: up to 8 months following implementation of the intervention.
The difference in the proportion of patients who delivered a neonate at 34+0 to 36+6 weeks' gestation who report having had a discussion about antenatal corticosteroids with their care provider pre-intervention versus post-intervention.
Secondary Outcomes
- The change in quality of clinical counselling about late preterm antenatal corticosteroids as assessed by the COMRADE scale.(up to 8 months following implementation of the intervention.)
Investigators
Jessica Liauw
Clinical Assistant Professor
University of British Columbia
